P947: Treatment Patterns and Outcomes of Re-Induction Therapies Prior to Stem Cell Transplantation in Patients With Relapsed/Refractory Multiple Myeloma Treated in Clinical Practice in Germany

Abstract

The efficacy of salvage stem cell transplantation (SCT) after re-induction with modern triplet or quadruplet regimens has been shown in clinical studies. However, there are limited data concerning the optimal choice of reinduction therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM) prior to salvage SCT in clinical practice.